Literature DB >> 6057803

Cryptococcus neoformans. I. Nonencapsulated mutants.

G S Bulmer, M D Sans, C M Gunn.   

Abstract

Seven nonencapsulated mutants of Cryptococcus neoformans were isolated from an encapsulated strain of human origin. Initially, the mutants were avirulent for mice. After several months of subculturing, six of the seven isolates reverted to the encapsulated state and possessed varying degrees of virulence. The results of these experiments suggest that a strong correlation exists between the presence of a capsule and the virulence of C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6057803      PMCID: PMC276850          DOI: 10.1128/jb.94.5.1475-1479.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Virulence and growth rates of Cryptococcus neoformans in mice.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  Ann N Y Acad Sci       Date:  1960-08-27       Impact factor: 5.691

2.  Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies.

Authors:  A KASE; J F METZGER
Journal:  J Bacteriol       Date:  1962-04       Impact factor: 3.490

3.  Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.

Authors:  M L LITTMAN; E TSUBURA
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

4.  The isolation of Cryptococcus neoformans from pigeon nests; with remarks on the identification of virulent cryptococci.

Authors:  C J KAO; J SCHWARZ
Journal:  Am J Clin Pathol       Date:  1957-06       Impact factor: 2.493

5.  [Capsular polyoside of a pathogenic fungus Torulopsis neoformans; relation to virulence].

Authors:  E DROUHET; G SEGRETAIN; J P AUBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1950-12

6.  Investigations on the structure of the capsular polysaccharide from Cryptococcus neoformans type B.

Authors:  A Blandamer; I Danishefsky
Journal:  Biochim Biophys Acta       Date:  1966-04-25
  6 in total
  72 in total

1.  Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.

Authors:  Amy J Reese; Aki Yoneda; Julia A Breger; Anne Beauvais; Hong Liu; Cara L Griffith; Indrani Bose; Myoung-Ju Kim; Colleen Skau; Sarah Yang; Julianne A Sefko; Masako Osumi; Jean-Paul Latge; Eleftherios Mylonakis; Tamara L Doering
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

Review 2.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

3.  Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Authors:  H S Emery; C P Shelburne; J P Bowman; P G Fallon; C A Schulz; E S Jacobson
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Host defense in Cryptococcosis. III. In vivo alteration of immunity.

Authors:  J R Graybill; L Mitchell
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

5.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

9.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.